Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a clinical-stage pharmaceutical company, today announced the commencement of a registered underwritten public offering of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Karyopharm Therapeutics (KPTI) Prices 9.15M Share Common Offering at $14.75/ShMay 3, 2018 5:37 AM Karyopharm Therapeutics Announces Proposed Public Offering of Common StockMay 1, 2018 4:34 PM